Cite Filings / VIR / 0001012975-26-001020

Feed Companies Filings Check

Sign in

SCHEDULE 13D/A

Beneficial Ownership Report

Vir Biotechnology, Inc. Filed 2026-11-06 Acc 0001012975-26-001020

Documents 1

SCHEDULE 13D/A Beneficial Ownership Report , xslSCHEDULE_13D_X02/primary_doc.xml

Around this filing

2026-11-09 8-K Regulation FD disclosure · Other events
2026-11-06 SCHEDULE 13D/A Beneficial Ownership Report
2026-11-04 10-Q Quarterly Report
2026-11-04 8-K Results of operations
2026-11-04 4 EVP, General Counsel, Corp Sec sold 3,750 shares at an average $11.18 ($41,939)
2026-11-03 144 Sale of Securities
2026-03-03 SCHEDULE 13D/A Beneficial Ownership Report

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading xslSCHEDULE_13D_X02/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…